Form 4: Envoy Medical CEO Brent Lucas Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Envoy Medical's CEO, Brent Lucas, reported a pro rata distribution of Class A Common Stock and stock option holdings.
Summary
- Brent Lucas, CEO of Envoy Medical, filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
- The report indicates a pro rata distribution of 74,784 Class A Common Stock shares and 10,176 Class A Common Stock shares from Cornerstone Growth Group, LP and Cornerstone Growth Group II, LP.
- Lucas also holds options to purchase 879,749 shares of Class A Common Stock, with 659,811 shares vesting on 10/15/2023 and 219,938 shares vesting pro rata monthly thereafter for 36 months.
- The reported transactions occurred on June 24, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors.
Key Dates
| Date | Description |
|---|---|
| 10/15/2023 | Vesting date for 659,811 stock options. |
| 06/24/2024 | Date of pro rata distribution of Class A Common Stock. |
| 10/15/2033 | Expiration date for stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.